NCT07313592

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-06-03Est. Completion: 2028-07-15

Enrollment target: 60 participants

Locations

Washington University School of Medicine/St. Louis Children's Hospital, St Louis, Missouri, United States

Contact

B-AllAcute Lymphoblastic Leukemia

Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…

Los Angeles, United StatesEst. completion Dec 31, 2026

Acute Lymphoblastic LeukemiaB-All

Background: Acute lymphoblastic leukemia (ALL) is a type of blood cancer. Chimeric antigen receptor (CAR) therapy invol…

Bethesda, United StatesEst. completion Jan 31, 2030

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.